Veru Inc. (NASDAQ:VERU) Shares Purchased by Jane Street Group LLC

Jane Street Group LLC increased its stake in shares of Veru Inc. (NASDAQ:VERU) by 142.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 96,454 shares of the company’s stock after buying an additional 56,736 shares during the quarter. Jane Street Group LLC’s holdings in Veru were worth $74,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in VERU. Perceptive Advisors LLC grew its holdings in shares of Veru by 26.5% in the second quarter. Perceptive Advisors LLC now owns 7,063,277 shares of the company’s stock valued at $5,942,000 after purchasing an additional 1,478,578 shares in the last quarter. PVG Asset Management Corp acquired a new position in shares of Veru in the second quarter valued at approximately $474,000. Bank of New York Mellon Corp grew its holdings in shares of Veru by 1,718.2% in the second quarter. Bank of New York Mellon Corp now owns 443,782 shares of the company’s stock valued at $373,000 after purchasing an additional 419,374 shares in the last quarter. Choreo LLC grew its holdings in shares of Veru by 261.3% in the second quarter. Choreo LLC now owns 332,050 shares of the company’s stock valued at $292,000 after purchasing an additional 240,134 shares in the last quarter. Finally, Squarepoint Ops LLC acquired a new position in shares of Veru in the second quarter valued at approximately $161,000. Hedge funds and other institutional investors own 47.16% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on VERU shares. Oppenheimer restated an “outperform” rating and issued a $5.00 price objective on shares of Veru in a report on Tuesday, November 5th. HC Wainwright reiterated a “buy” rating and set a $3.00 price target on shares of Veru in a report on Thursday, January 2nd.

Veru Stock Down 0.4 %

NASDAQ:VERU opened at $0.74 on Thursday. Veru Inc. has a fifty-two week low of $0.36 and a fifty-two week high of $1.92. The stock has a market cap of $108.40 million, a PE ratio of -1.54 and a beta of -0.53. The firm’s fifty day simple moving average is $0.69 and its 200-day simple moving average is $0.80.

Veru (NASDAQ:VERU) last issued its quarterly earnings data on Monday, December 16th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Veru had a negative net margin of 376.38% and a negative return on equity of 115.99%. Equities analysts anticipate that Veru Inc. will post -0.3 earnings per share for the current year.

Veru Company Profile

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.